Daxor (DXR) said Tuesday it has been issued a patent related to its remote blood volume monitor technology by the United States Patent and Trademark Office.
The patent covers systems and methods for the ongoing and remote monitoring of a patient's absolute blood volume status after an initial baseline measurement, the company said.